The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ketorolac Injection Market Research Report 2025
Synopsis
Ketorolac injection is used for the short-term treatment of moderate to severe pain. It is usually used before or after medical procedures or after surgery. Reducing pain helps you recover more comfortably so that you can return to your normal daily activities. This medication is a nonsteroidal anti-inflammatory drug.
The global Ketorolac Injection market was valued at US$ 939.8 million in 2023 and is anticipated to reach US$ 1125.6 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
Global key ketorolac injection 核心厂商 Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma) etc. The top 2 companies hold a share about 20%. North America is the largest market, with a share about 40%, followed by Asia-Pacific and Europe with the share about 27% and 20%. In terms of product, 30mg/ml ketorolac injection is the largest segment, with a share over 64%. And in terms of application, the largest application is hospital, followed by clinics.
This report aims to provide a comprehensive presentation of the global market for Ketorolac Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ketorolac Injection.
Report Scope
The Ketorolac Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ketorolac Injection market comprehensively. Regional market sizes, concerning products by Concentration, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ketorolac Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Concentration, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Fresenius Kabi
Fosun Pharma (Gland Pharma)
Sagent Pharmaceuticals
Hikma
Lunan Pharma
Alvogen
Chengdu Brilliant Pharmaceuticals
Athenex
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
Tianjin Chase Sun Pharmaceutical
ZISKA Pharmaceuticals
Segment by Concentration
15mg/ml
30mg/ml
Segment by Application
Hospital
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Concentration, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ketorolac Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ketorolac Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Concentration, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Ketorolac injection is used for the short-term treatment of moderate to severe pain. It is usually used before or after medical procedures or after surgery. Reducing pain helps you recover more comfortably so that you can return to your normal daily activities. This medication is a nonsteroidal anti-inflammatory drug.
The global Ketorolac Injection market was valued at US$ 939.8 million in 2023 and is anticipated to reach US$ 1125.6 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
Global key ketorolac injection 核心厂商 Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma) etc. The top 2 companies hold a share about 20%. North America is the largest market, with a share about 40%, followed by Asia-Pacific and Europe with the share about 27% and 20%. In terms of product, 30mg/ml ketorolac injection is the largest segment, with a share over 64%. And in terms of application, the largest application is hospital, followed by clinics.
This report aims to provide a comprehensive presentation of the global market for Ketorolac Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ketorolac Injection.
Report Scope
The Ketorolac Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ketorolac Injection market comprehensively. Regional market sizes, concerning products by Concentration, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ketorolac Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Concentration, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Fresenius Kabi
Fosun Pharma (Gland Pharma)
Sagent Pharmaceuticals
Hikma
Lunan Pharma
Alvogen
Chengdu Brilliant Pharmaceuticals
Athenex
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
Tianjin Chase Sun Pharmaceutical
ZISKA Pharmaceuticals
Segment by Concentration
15mg/ml
30mg/ml
Segment by Application
Hospital
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Concentration, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ketorolac Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ketorolac Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Concentration, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Ketorolac Injection Market Overview
1.1 Product Overview and Scope of Ketorolac Injection
1.2 Ketorolac Injection Segment by Concentration
1.2.1 Global Ketorolac Injection Market Value Comparison by Concentration (2024-2030)
1.2.2 15mg/ml
1.2.3 30mg/ml
1.3 Ketorolac Injection Segment by Application
1.3.1 Global Ketorolac Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Global Ketorolac Injection Market Size Estimates and Forecasts
1.4.1 Global Ketorolac Injection Revenue 2019-2030
1.4.2 Global Ketorolac Injection Sales 2019-2030
1.4.3 Global Ketorolac Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ketorolac Injection Market Competition by Manufacturers
2.1 Global Ketorolac Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ketorolac Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ketorolac Injection Average Price by Manufacturers (2019-2024)
2.4 Global Ketorolac Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ketorolac Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ketorolac Injection, Product Type & Application
2.7 Ketorolac Injection Market Competitive Situation and Trends
2.7.1 Ketorolac Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ketorolac Injection Players Market Share by Revenue
2.7.3 Global Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ketorolac Injection Retrospective Market Scenario by Region
3.1 Global Ketorolac Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ketorolac Injection Global Ketorolac Injection Sales by Region: 2019-2030
3.2.1 Global Ketorolac Injection Sales by Region: 2019-2024
3.2.2 Global Ketorolac Injection Sales by Region: 2025-2030
3.3 Global Ketorolac Injection Global Ketorolac Injection Revenue by Region: 2019-2030
3.3.1 Global Ketorolac Injection Revenue by Region: 2019-2024
3.3.2 Global Ketorolac Injection Revenue by Region: 2025-2030
3.4 North America Ketorolac Injection Market Facts & Figures by Country
3.4.1 North America Ketorolac Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ketorolac Injection Sales by Country (2019-2030)
3.4.3 North America Ketorolac Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ketorolac Injection Market Facts & Figures by Country
3.5.1 Europe Ketorolac Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ketorolac Injection Sales by Country (2019-2030)
3.5.3 Europe Ketorolac Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ketorolac Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Ketorolac Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ketorolac Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Ketorolac Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Ketorolac Injection Market Facts & Figures by Country
3.7.1 Latin America Ketorolac Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ketorolac Injection Sales by Country (2019-2030)
3.7.3 Latin America Ketorolac Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ketorolac Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Ketorolac Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ketorolac Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ketorolac Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Concentration
4.1 Global Ketorolac Injection Sales by Concentration (2019-2030)
4.1.1 Global Ketorolac Injection Sales by Concentration (2019-2024)
4.1.2 Global Ketorolac Injection Sales by Concentration (2025-2030)
4.1.3 Global Ketorolac Injection Sales Market Share by Concentration (2019-2030)
4.2 Global Ketorolac Injection Revenue by Concentration (2019-2030)
4.2.1 Global Ketorolac Injection Revenue by Concentration (2019-2024)
4.2.2 Global Ketorolac Injection Revenue by Concentration (2025-2030)
4.2.3 Global Ketorolac Injection Revenue Market Share by Concentration (2019-2030)
4.3 Global Ketorolac Injection Price by Concentration (2019-2030)
5 Segment by Application
5.1 Global Ketorolac Injection Sales by Application (2019-2030)
5.1.1 Global Ketorolac Injection Sales by Application (2019-2024)
5.1.2 Global Ketorolac Injection Sales by Application (2025-2030)
5.1.3 Global Ketorolac Injection Sales Market Share by Application (2019-2030)
5.2 Global Ketorolac Injection Revenue by Application (2019-2030)
5.2.1 Global Ketorolac Injection Revenue by Application (2019-2024)
5.2.2 Global Ketorolac Injection Revenue by Application (2025-2030)
5.2.3 Global Ketorolac Injection Revenue Market Share by Application (2019-2030)
5.3 Global Ketorolac Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Ketorolac Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Fresenius Kabi
6.2.1 Fresenius Kabi Corporation Information
6.2.2 Fresenius Kabi Description and Business Overview
6.2.3 Fresenius Kabi Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Fresenius Kabi Ketorolac Injection Product Portfolio
6.2.5 Fresenius Kabi Recent Developments/Updates
6.3 Fosun Pharma (Gland Pharma)
6.3.1 Fosun Pharma (Gland Pharma) Corporation Information
6.3.2 Fosun Pharma (Gland Pharma) Description and Business Overview
6.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio
6.3.5 Fosun Pharma (Gland Pharma) Recent Developments/Updates
6.4 Sagent Pharmaceuticals
6.4.1 Sagent Pharmaceuticals Corporation Information
6.4.2 Sagent Pharmaceuticals Description and Business Overview
6.4.3 Sagent Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sagent Pharmaceuticals Ketorolac Injection Product Portfolio
6.4.5 Sagent Pharmaceuticals Recent Developments/Updates
6.5 Hikma
6.5.1 Hikma Corporation Information
6.5.2 Hikma Description and Business Overview
6.5.3 Hikma Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hikma Ketorolac Injection Product Portfolio
6.5.5 Hikma Recent Developments/Updates
6.6 Lunan Pharma
6.6.1 Lunan Pharma Corporation Information
6.6.2 Lunan Pharma Description and Business Overview
6.6.3 Lunan Pharma Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lunan Pharma Ketorolac Injection Product Portfolio
6.6.5 Lunan Pharma Recent Developments/Updates
6.7 Alvogen
6.6.1 Alvogen Corporation Information
6.6.2 Alvogen Description and Business Overview
6.6.3 Alvogen Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Alvogen Ketorolac Injection Product Portfolio
6.7.5 Alvogen Recent Developments/Updates
6.8 Chengdu Brilliant Pharmaceuticals
6.8.1 Chengdu Brilliant Pharmaceuticals Corporation Information
6.8.2 Chengdu Brilliant Pharmaceuticals Description and Business Overview
6.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio
6.8.5 Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
6.9 Athenex
6.9.1 Athenex Corporation Information
6.9.2 Athenex Description and Business Overview
6.9.3 Athenex Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Athenex Ketorolac Injection Product Portfolio
6.9.5 Athenex Recent Developments/Updates
6.10 Sichuan Medcalo
6.10.1 Sichuan Medcalo Corporation Information
6.10.2 Sichuan Medcalo Description and Business Overview
6.10.3 Sichuan Medcalo Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sichuan Medcalo Ketorolac Injection Product Portfolio
6.10.5 Sichuan Medcalo Recent Developments/Updates
6.11 Julphar Bangladesh Ltd.
6.11.1 Julphar Bangladesh Ltd. Corporation Information
6.11.2 Julphar Bangladesh Ltd. Ketorolac Injection Description and Business Overview
6.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio
6.11.5 Julphar Bangladesh Ltd. Recent Developments/Updates
6.12 Yung Shin Pharm
6.12.1 Yung Shin Pharm Corporation Information
6.12.2 Yung Shin Pharm Ketorolac Injection Description and Business Overview
6.12.3 Yung Shin Pharm Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Yung Shin Pharm Ketorolac Injection Product Portfolio
6.12.5 Yung Shin Pharm Recent Developments/Updates
6.13 Tianjin Chase Sun Pharmaceutical
6.13.1 Tianjin Chase Sun Pharmaceutical Corporation Information
6.13.2 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Description and Business Overview
6.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio
6.13.5 Tianjin Chase Sun Pharmaceutical Recent Developments/Updates
6.14 ZISKA Pharmaceuticals
6.14.1 ZISKA Pharmaceuticals Corporation Information
6.14.2 ZISKA Pharmaceuticals Ketorolac Injection Description and Business Overview
6.14.3 ZISKA Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.14.4 ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio
6.14.5 ZISKA Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ketorolac Injection Industry Chain Analysis
7.2 Ketorolac Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ketorolac Injection Production Mode & Process
7.4 Ketorolac Injection Sales and Marketing
7.4.1 Ketorolac Injection Sales Channels
7.4.2 Ketorolac Injection Distributors
7.5 Ketorolac Injection Customers
8 Ketorolac Injection Market Dynamics
8.1 Ketorolac Injection Industry Trends
8.2 Ketorolac Injection Market Drivers
8.3 Ketorolac Injection Market Challenges
8.4 Ketorolac Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Ketorolac Injection Market Value Comparison by Concentration (2024-2030) & (US$ Million)
Table 2. Global Ketorolac Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Ketorolac Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Ketorolac Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Ketorolac Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Ketorolac Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Ketorolac Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Ketorolac Injection Average Price (US$/K Units) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Ketorolac Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Ketorolac Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Ketorolac Injection, Product Type & Application
Table 12. Global Key Manufacturers of Ketorolac Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ketorolac Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Ketorolac Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Ketorolac Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Ketorolac Injection Sales Market Share by Region (2019-2024)
Table 19. Global Ketorolac Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Ketorolac Injection Sales Market Share by Region (2025-2030)
Table 21. Global Ketorolac Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Ketorolac Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Ketorolac Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Ketorolac Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Ketorolac Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Ketorolac Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Ketorolac Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Ketorolac Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Ketorolac Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Ketorolac Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Ketorolac Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Ketorolac Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Ketorolac Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Ketorolac Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Ketorolac Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Ketorolac Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Ketorolac Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Ketorolac Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Ketorolac Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Ketorolac Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Ketorolac Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Ketorolac Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Ketorolac Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Ketorolac Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Ketorolac Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Ketorolac Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Ketorolac Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Ketorolac Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Ketorolac Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Ketorolac Injection Sales (K Units) by Concentration (2019-2024)
Table 51. Global Ketorolac Injection Sales (K Units) by Concentration (2025-2030)
Table 52. Global Ketorolac Injection Sales Market Share by Concentration (2019-2024)
Table 53. Global Ketorolac Injection Sales Market Share by Concentration (2025-2030)
Table 54. Global Ketorolac Injection Revenue (US$ Million) by Concentration (2019-2024)
Table 55. Global Ketorolac Injection Revenue (US$ Million) by Concentration (2025-2030)
Table 56. Global Ketorolac Injection Revenue Market Share by Concentration (2019-2024)
Table 57. Global Ketorolac Injection Revenue Market Share by Concentration (2025-2030)
Table 58. Global Ketorolac Injection Price (US$/K Units) by Concentration (2019-2024)
Table 59. Global Ketorolac Injection Price (US$/K Units) by Concentration (2025-2030)
Table 60. Global Ketorolac Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Ketorolac Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Ketorolac Injection Sales Market Share by Application (2019-2024)
Table 63. Global Ketorolac Injection Sales Market Share by Application (2025-2030)
Table 64. Global Ketorolac Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Ketorolac Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Ketorolac Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Ketorolac Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Ketorolac Injection Price (US$/K Units) by Application (2019-2024)
Table 69. Global Ketorolac Injection Price (US$/K Units) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 73. Pfizer Ketorolac Injection Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Fresenius Kabi Corporation Information
Table 76. Fresenius Kabi Description and Business Overview
Table 77. Fresenius Kabi Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 78. Fresenius Kabi Ketorolac Injection Product
Table 79. Fresenius Kabi Recent Developments/Updates
Table 80. Fosun Pharma (Gland Pharma) Corporation Information
Table 81. Fosun Pharma (Gland Pharma) Description and Business Overview
Table 82. Fosun Pharma (Gland Pharma) Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 83. Fosun Pharma (Gland Pharma) Ketorolac Injection Product
Table 84. Fosun Pharma (Gland Pharma) Recent Developments/Updates
Table 85. Sagent Pharmaceuticals Corporation Information
Table 86. Sagent Pharmaceuticals Description and Business Overview
Table 87. Sagent Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 88. Sagent Pharmaceuticals Ketorolac Injection Product
Table 89. Sagent Pharmaceuticals Recent Developments/Updates
Table 90. Hikma Corporation Information
Table 91. Hikma Description and Business Overview
Table 92. Hikma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 93. Hikma Ketorolac Injection Product
Table 94. Hikma Recent Developments/Updates
Table 95. Lunan Pharma Corporation Information
Table 96. Lunan Pharma Description and Business Overview
Table 97. Lunan Pharma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 98. Lunan Pharma Ketorolac Injection Product
Table 99. Lunan Pharma Recent Developments/Updates
Table 100. Alvogen Corporation Information
Table 101. Alvogen Description and Business Overview
Table 102. Alvogen Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 103. Alvogen Ketorolac Injection Product
Table 104. Alvogen Recent Developments/Updates
Table 105. Chengdu Brilliant Pharmaceuticals Corporation Information
Table 106. Chengdu Brilliant Pharmaceuticals Description and Business Overview
Table 107. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 108. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product
Table 109. Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
Table 110. Athenex Corporation Information
Table 111. Athenex Description and Business Overview
Table 112. Athenex Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 113. Athenex Ketorolac Injection Product
Table 114. Athenex Recent Developments/Updates
Table 115. Sichuan Medcalo Corporation Information
Table 116. Sichuan Medcalo Description and Business Overview
Table 117. Sichuan Medcalo Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 118. Sichuan Medcalo Ketorolac Injection Product
Table 119. Sichuan Medcalo Recent Developments/Updates
Table 120. Julphar Bangladesh Ltd. Corporation Information
Table 121. Julphar Bangladesh Ltd. Description and Business Overview
Table 122. Julphar Bangladesh Ltd. Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 123. Julphar Bangladesh Ltd. Ketorolac Injection Product
Table 124. Julphar Bangladesh Ltd. Recent Developments/Updates
Table 125. Yung Shin Pharm Corporation Information
Table 126. Yung Shin Pharm Description and Business Overview
Table 127. Yung Shin Pharm Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 128. Yung Shin Pharm Ketorolac Injection Product
Table 129. Yung Shin Pharm Recent Developments/Updates
Table 130. Tianjin Chase Sun Pharmaceutical Corporation Information
Table 131. Tianjin Chase Sun Pharmaceutical Description and Business Overview
Table 132. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 133. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product
Table 134. Tianjin Chase Sun Pharmaceutical Recent Developments/Updates
Table 135. ZISKA Pharmaceuticals Corporation Information
Table 136. ZISKA Pharmaceuticals Description and Business Overview
Table 137. ZISKA Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 138. ZISKA Pharmaceuticals Ketorolac Injection Product
Table 139. ZISKA Pharmaceuticals Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Ketorolac Injection Distributors List
Table 143. Ketorolac Injection Customers List
Table 144. Ketorolac Injection Market Trends
Table 145. Ketorolac Injection Market Drivers
Table 146. Ketorolac Injection Market Challenges
Table 147. Ketorolac Injection Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ketorolac Injection
Figure 2. Global Ketorolac Injection Market Value Comparison by Concentration (2024-2030) & (US$ Million)
Figure 3. Global Ketorolac Injection Market Share by Concentration in 2023 & 2030
Figure 4. 15mg/ml Product Picture
Figure 5. 30mg/ml Product Picture
Figure 6. Global Ketorolac Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Ketorolac Injection Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Ketorolac Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Ketorolac Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Ketorolac Injection Sales (2019-2030) & (K Units)
Figure 14. Global Ketorolac Injection Average Price (US$/K Units) & (2019-2030)
Figure 15. Ketorolac Injection Report Years Considered
Figure 16. Ketorolac Injection Sales Share by Manufacturers in 2023
Figure 17. Global Ketorolac Injection Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Ketorolac Injection Players: Market Share by Revenue in 2023
Figure 19. Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Ketorolac Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Ketorolac Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Ketorolac Injection Revenue Market Share by Country (2019-2030)
Figure 23. United States Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Ketorolac Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Ketorolac Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Ketorolac Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Ketorolac Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Ketorolac Injection Sales Market Share by Country (2019-2030)
Figure 44. Latin America Ketorolac Injection Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Ketorolac Injection Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Ketorolac Injection Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Ketorolac Injection by Concentration (2019-2030)
Figure 54. Global Revenue Market Share of Ketorolac Injection by Concentration (2019-2030)
Figure 55. Global Ketorolac Injection Price (US$/K Units) by Concentration (2019-2030)
Figure 56. Global Sales Market Share of Ketorolac Injection by Application (2019-2030)
Figure 57. Global Revenue Market Share of Ketorolac Injection by Application (2019-2030)
Figure 58. Global Ketorolac Injection Price (US$/K Units) by Application (2019-2030)
Figure 59. Ketorolac Injection Value Chain
Figure 60. Ketorolac Injection Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
